CTRI/2020/09/027951招募中未知
Comparison of Pharmacokinetic Principles of Anti-tubercular Drugs in Tuberculosis (TB) with and without Chronic Kidney Disease (CKD).
Indian Council of Medical Research Technically Approved Awaiting for further response0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1- Tuberculosis (TB) with Chronic Kidney Disease (CKD) group
- •a. Age group between 18 to 70
- •b. Patients with CKD having tuberculosis and received
- •treatment minimum for two weeks.
- •2- Tuberculosis (TB) without Chronic Kidney Disease (CKD) group
- •a.Age group between 18 to 70
- •b.Patients with tuberculosis received treatment minimum for two weeks.
- •3-Chronic kidney Disease patients with dialysis group
- •a.Age group between 18 to 70
- •b.Patients of CKD on maintenance of dialysis and
- •having tuberculosis received treatment minimum for two weeks.
排除标准
- •a.Human immunodeficiency virus (HIV) infected subjects
- •b.Viral Hepatitis
- •c.Any Hepatic Disease Subjects
- •d.Renal transplantation subjects
- •b.Acute Kidney Injury Subjects
- •c.Non-adherence to medication: It is defined as If patients take less than 80% of their prescribed medication(s), they are considered nonadherent.
- •d.Pregnant women
研究者
相似试验
进行中（未招募）
1 期
DIFFERENTIATING THE MECHANISM OF ACTION OF ANTI TNF-alpha AGENTS - DATA StudyEUCTR2006-000363-28-GBGreater Glasgow Health Board40
已完成
不适用
Comparison of the pharmacokinetics between the initial and reduced dose of S-1 in the patients with locally advanced head and neck cancerlocally advanced head and neck cancerJPRN-UMIN000025205ational Cancer Center Hospital East25
已完成
不适用
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Low Body Weight versus Higher Body Weight Aspirin-Treated Subjects with Stable Coronary Artery Diseaseillness of coronary arteries10011082Coronary Artery DiseaseNL-OMON34026Eli Lilly25
进行中（未招募）
不适用
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis - TABREUCTR2005-005292-15-SEEli Lilly and Company Ltd.110
已完成
不适用
A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Very Elderly versus Non-Elderly Aspirin-Treated Subjects with Stable Coronary Artery DiseaseCoronary Artery Diseaseillness of coronary arteries10011082NL-OMON34156Eli Lilly20